Lincoln Pharmaceuticals Quarterly Results for Trading Insights
LINCOLN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹20 Cr
QSept 2025
Lincoln Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹171 Cr in Sept 2025 (+6.2% vs Mar 2025, +0.0% vs Sept 2024)
- Net Profit of ₹20 Cr in Sept 2025 (+66.7% vs Mar 2025, -23.1% vs Sept 2024)
- EBITDA of ₹33 Cr in Sept 2025 (+65.0% vs Mar 2025)
- Operating Margin of 16.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹9.98 in Sept 2025 (+72.7% vs Mar 2025)
Lincoln Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 171 | 161 | 169 | 182 | 171 | 6.2% | - |
| Net Profit (₹ Cr) | 20 | 12 | 28 | 29 | 26 | - | - |
| EBITDA (₹ Cr) | 33 | 20 | 39 | 39 | 38 | - | - |
| EPS (₹) | 9.98 | 5.78 | 13.82 | 14.28 | 13.15 | - | - |
| Operating Margin (%) | 16.0% | 16.0% | 15.0% | 14.0% | 18.0% | - | - |
Lincoln Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Lincoln Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for Lincoln Pharmaceuticals
Additional stock information and data for LINCOLN
Revenue Trend (₹ Cr)
Dec 2025
182
Jun 2025
169
Mar 2025
161
Sept 2025
171
Net Profit Trend (₹ Cr)
Dec 2025
29
Jun 2025
28
Mar 2025
12
Sept 2025
20
Operating Margin Trend (%)
Dec 2025
14.0%
Jun 2025
15.0%
Mar 2025
16.0%
Sept 2025
16.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Lincoln Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹430,344.72 Cr | 1757.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.2 |
|
Divis Laboratories
Sept 2025 |
₹159,214.78 Cr | 5947.0 | 2,860 | 689 | +7.1% | - | 24.1% | 229.0 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹144,367.29 Cr | 4220.2 | 3,219 | 591 | +11.3% | - | 18.4% | 240.6 |
|
Lupin
Sept 2025 |
₹107,238.09 Cr | 2313.9 | 6,921 | 1,485 | +23.2% | - | 21.5% | 71.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,974.57 Cr | 1254.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores